Parabo.Drugs - Press Release

Subscribe to GoodReturns

Parabolic Drugs Ltd has informed BSE vide its letter dated April 18, 2011 regarding a Press Release with respect to Certificate of Suitability (COS) granted to the Company in respect of its one of key molecule namely "Cefixime".

Read more about: parabolic drugs ltd
Please Wait while comments are loading...
Company Search
Enter the first few characters of the company's name or the NSE symbol or BSE code and click 'Go'

Thousands of Goodreturn readers receive our evening newsletter.
Have you subscribed?